ASCO Chicago, May 31 – June 3, 2024
June 5, 2024
Immunophotonics co-founders Lu Alleruzzo (CEO) and Tomas Hode, PhD (CIO and President) will be in Chicago at the ASCO (American…
Immunophotonics Announces the Addition of Jacqueline Hess to its Advisory Board
May 1, 2024
Immunophotonics, Inc. is delighted to introduce Jacqueline Hess as the newest addition to our advisory board. Ms. Hess has over 25 years…
European Conference on Interventional Oncology (ECIO), April 28 – May 1, 2024
April 24, 2024
Tomas Hode, PhD, who serves as the Co-Founder, CIO, and President at Immunophotonics, Inc., will be attending the European Conference…
Swiss Biotech Day, April 22 – 23, 2024
April 24, 2024
Immunophotonics is thrilled to share that Dr. Theresa Visarius from Immunophotonics Switzerland (IPS Biopharma) will be attending the Swiss Biotech…
AngioDynamics International Life Symposium “The Human Touch, Behind Innovation” March 21–23, 2024
March 20, 2024
Tomas Hode, PhD, who serves as the Co-Founder, CIO, and President at Immunophotonics, Inc. is eager to attend the AngioDynamics…
MOBIO to feature Immunophotonics as the Member Highlight for March
March 13, 2024
Immunophotonics to be showcased as the Member Highlight for March by The Missouri Biotechnology Association (MOBIO), both on their homepage…
AngioDynamics and Immunophotonics Announces Partnership to Explore the Power of Immunotherapy
February 28, 2024
Immunophotonics Lu Alleruzzo, CEO and Tomas Hode, PhD, CIO, and President have announced a partnership that will combine use of…
Immunophotonics presenting at the Global Life Science Partnering & Investor Conference February 27-29, 2024
February 28, 2024
Immunophotonics, Inc. is grateful to NCI (National Cancer Institute) SBIR Investor Initiatives Team for providing us the opportunity to showcase…
Wei Chen’s Publication in Acta Biomaterialia Journal
February 13, 2024
Congratulations to Professor Wei Chen and his lab at the University of Oklahoma, along with contributors Lu Alleruzzo, Samuel S.K.…
St. Louis cancer drug startup’s expansion plans include research pact with pharma giant
January 24, 2024
St. Louis cancer drug startup Immunophotonics Inc. will pursue expansion of its lead drug candidate through a partnership with the…